chrisvoncsefalvay/vaers-outcomes huggingface dataset:
punctured 18 hours before vaccination; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (punctured 18 hours before vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (punctured 18 hours before vaccination). At the time of the report, EXPIRED PRODUCT ADMINISTERED (punctured 18 hours before vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Relevant concomitant medications was reported.  Treatment information was not provided.
Since receiving the COVID 19 pfizer booster, patient has complained of frequent recurrent dizziness and difficulty breathing.  The difficulty breathing is mostly with exercise.  The dizziness started as mostly with exercise but is now happening unrelated to exercise.  Has been happening for the past 7 months.
POSSIBLE PULMONARY EMBOLISM; ELEVATED D-DIMER; This spontaneous report received from a patient concerned a 55 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: ER8729, and expiry: UNKNOWN) dose was not reported, 1 total administered on 07-APR-2021 at around 10:00 on left arm for prophylactic vaccination. No concomitant medications were reported.  On 16-APR-2021, the patient experienced shortness of breath that worsened with exertion, and at the time of reporting at rest. Patient called her physician (MD) (internist) and went to the office on 23-APR-2021 for some testing. She had an elevated d-dimer level. Laboratory data included: Fibrin D dimer high (NR: not provided) Elevated. The physician treated her for possible pulmonary embolism. On same day she experienced pressure in her chest. At the time of reporting patient had shortness of breath and occasionally some pressure in her chest. Patient did not take any medications for her symptoms.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from elevated d-dimer, and possible pulmonary embolism. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:  This spontaneous case describes a 55-year-old female who experienced shortness of breath which worsened with exertion 9 days after receiving the Janssen COVID-19 vaccine.  She then experienced chest pressure 16 days after vaccine administration, and saw her physician that day.  D-dimer level was elevated, and the physician treated her for a possible pulmonary embolism.  Medical history and concomitant medications were not provided.  The patient had not recovered from the events.  There are insufficient details in the case to make a meaningful medical assessment. The case will be assessed further when additional information is received.
Initial report received on 22 July 2008 from a health professional. A 14-year-old female patient (Initials not provided), with "unknown" past medical history, had received on an  unspecified date, a dose of ADACEL vaccine, MENACTRA vaccine and GARDASIL vaccine (manufacturer MERCK). The lot numbers, routes and sites of administration were not provided for any of the vaccines. At an unspecified amount of time later, after receiving the three vaccines, the patient was described as "blowing up like a balloon" with swelling of the face and legs. The patient was admitted to the hospital (date not specified); however, treatments received and diagnostic tests performed were not provided. At the time of this report, the recovery status of the patient was "unknown."
some parts are very very red in her neck; fatigue; burning sensation all over her neck and shoulders; cold; night sweat; fever\little higher fever; headache\extreme headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BURNING SENSATION (burning sensation all over her neck and shoulders), NASOPHARYNGITIS (cold), NIGHT SWEATS (night sweat), ERYTHEMA (some parts are very very red in her neck) and FATIGUE (fatigue) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse reaction (no medical history reported.). Concomitant products included VITAMIN D3, CYANOCOBALAMIN (VIT B12), PYRIDOXINE HYDROCHLORIDE (VIT B6) and ZINC for an unknown indication.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced NASOPHARYNGITIS (cold), NIGHT SWEATS (night sweat), PYREXIA (fever\little higher fever) and HEADACHE (headache\extreme headache). On 12-Apr-2021, the patient experienced BURNING SENSATION (burning sensation all over her neck and shoulders), ERYTHEMA (some parts are very very red in her neck) and FATIGUE (fatigue). At the time of the report, BURNING SENSATION (burning sensation all over her neck and shoulders), NASOPHARYNGITIS (cold), NIGHT SWEATS (night sweat), ERYTHEMA (some parts are very very red in her neck), FATIGUE (fatigue), PYREXIA (fever\little higher fever) and HEADACHE (headache\extreme headache) outcome was unknown.            Treatment is with Benadryl, Hydroxyzine 25 mg 1 every 8 hour and prednisone 20 mg 1 tablet for 5 days. concomitant medications include high blood pressure medicine and HIV medicine along with mentioned above.   This case was linked to US-MODERNATX, INC.-MOD-2021-079307 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-079307:DOSE 1
received Fluarix after expiration date; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number 5D4H4, expiry date 30th June 2021) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   In October 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. In October 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported that the patient received expired dose of Fluarix QV, which led to expired vaccine used.  The reporter consented to follow up by email.  No details from patients involved were available. This is 1 of 4 cases reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021211489:same reporter US-GLAXOSMITHKLINE-US2021211493:same reporter US-GLAXOSMITHKLINE-US2021211495:same reporter
Information has been received from a physician concerning a 14 month old Caucasian female with no previous significant medical history, no known illness at the time of vaccination, no known recent varicella or herpes exposure and no previous history of chicken pox, who on 17 JUL 2001 (previously reported as 2 months ago, in approximately May 2001 and also as 07 JUL 2001 was vaccinated with the first .5 mL dose (lot #638653/1890K) of varicella virus vaccine live administered SC in the right arm (also reported as the left arm/deltoid. There was no concomitant medication. It was reported that on 30 JUL 2001, the patient was seen at the physician's office for follow up to an ear infection. That same day, she was diagnosed with herpes zoster that began on 29 JUL 2001. The physician noted that a varicella zoster or herpes zoster like presentation oh the child's nose. It was reported that the multiple, small, vesicular lesions were clustered, primarily on the left side of her nose and did not cross the midline. This was also described as multiple blisters on the end of the left nostril. It was reported on 01 AUG 2001 that the patient did not have a fever and had no other symptoms. A specimen, consisting of 2 swabs, was collected from vesicular lesions and sent for varicella zoster virus identification on 31 JUL 2001. The lab received the specimen on 01 AUG 2001. On 24 AUG 2001, notification was received from the lab that VZV DNA and B-globin DNA were not amplified and that the specimen was inadequate to process; therefore, no strain ID was made and a direct fluorescent antibody test was not performed. It was noted that the patient did not develop a rash at the injection site or elsewhere within 42 days of the vaccination. Subsequently, it was reported that the patient recovered from her experience. No further information is available.
Had really bazar nighmares - some sweating, slight headace, backpain and join pain - particularly my knees and feet joints.  Some pinching pain in my lungs.  I did not experience any shortness of breath.  Am currently taking aspirin for the effects.  Seems to be helping.  Had a temp of 100.2 this morning.  Now is 98.2 - but still my body is hot and maybe this is due to the activation of the vaccine and my body trying to fight it.
Febrile seizure possible flu vaccine related. 12/13/06-records reviewed. ER visit 11/7/06- DX:Febrile illness and febrile seizure Pneumonia Bilateral otitis. Temp at home after seizure 100. Temp in ER 103 (R) Transferred to Hospital ovenight stay Follow up visit with PCP on 11/9/06-mild congestion. lungs CTA
I started to have fever and chills about 6-7 hours after receiving the Moderna booster. I went to sleep in the evening and woke in the middle of the night with severe chills, sweating, headache, nausea, and a feeling of rigidity in the muscles of my forearms and wrists, with involuntary contraction of my hands. I wasn't in a condition to check my temperature with a thermometer. I took two aspirin, drank some cold water, and the chills improved and the muscle rigidity and hand contraction went away. I continued to have chills, headache and nausea return every 4-6 hours, into the next day, which I alleviated with 1-2 aspirin during each interval. By the next afternoon, about a day after receiving the booster, I was feeling subjectively much better and measured my temperature with an oral thermometer: it was 102 Fahrenheit. Two days subsequently, I noticed a palpable left axillary lymph node, which persisted for another 2-3 days. Altogether, these symptoms were similar but to a worse degree than what I experienced after the second dose of the Pfizer vaccine nine months earlier. However, the fever seemed higher and came on faster; the muscle rigidity/hand contraction, and axillary lymphadenopathy were new symptoms.
consumer reports that his wife exp an apparent allergic rxn consisting of eruption & itching; consumer would not provide addtl info;
Felt bad; This case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, less than 5 months after receiving Shingles vaccine, the patient experienced feeling bad. On an unknown date, the outcome of the feeling bad was recovered/resolved.   It was unknown if the reporter considered the feeling bad to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported, but was selected as an adult as per vaccine indication. The patient had first shot of Shingrix and felt bad for a day. For tolerance of second dose refer case ID US2021AMR064388.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR064388:same reporter
Swollen at site. Entire arm, right side neck, jaw and face sore. Bells palsy right side migraine, fever.
After her second vaccine on 6/3/2021, she was severely ill with a fever of Tmax 104F for 4 days, myalgia vomiting, and diarrhea. Immediately afterwards, she developed a trigger finger sensation to her dominant right hand as if it was "locked up." She was unable to hold a pen to write her name or floss her teeth.
Upper 3/4 of R arm red, swollen, itchy and warm post injection, outer aspect only.
SEEING BLACK SPOTS ALL AROUND; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included: alcohol use. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced seeing black spots all around. The action taken with covid-19 vaccine was not applicable. The outcome of seeing black spots all around was not reported. This report was non-serious. This case, from the same reporter is linked to 20210912958 and 20210913421.
pt had localized redness to the area, has lasted for 8 days now, a little tender upon pushing on the arm
I tested positive for COVID-19 on 4/25/23. I started having laryngitis first and I thought it was because I went to a concert. The next night I started to feel bad, and I took a cough drop and couldn't taste it. I also had chills, body aches, fatigue, congestion, and fever of 101. I contacted my doctor and was prescribed PAXLOVID. I am still dealing with some of these symptoms at this time.
Nausea and vomiting at 11:00 p.m. on the night I received the vaccine; 04.16.21.  Diarrhea from 5:00 p.m. on 04.17.21 through the time of this report.  Nausea has not subsided since 04.16.21.  No further episodes of vomiting since 04.16.21.
Pt recv vax & devel inj site rxn w/1.2-cm area of redness,induration & tenderness. This is 1 of 2 pt from this site to exp adverse rxn p/vax
Quarter size red rash about an inch below the injection site was detected around 8am on 5/29/2019.  By 3:30pm 5/29/2019, the rash was about the size of a silver dollar and a secondary rash about the size of a nickel appeared near it. Mild muscle ache exists, but it is much less than when I had the first vaccine in March 2019. Vaccine number 1 had no side effects, just sore muscle.
Sudden appearance of skin tumor on left forearm,  Confirmed biopsy , squamous cell with keratoacanthomatous features.  Also sharp  unusual pain in both wrist bone areas, and sharp pains extending on back of left hand.
Tightness in the chest; Vaccine spilled; Re-vaccinated patient; Vaccine spilled; Body aches; Severe fatigue; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of CHEST DISCOMFORT (Tightness in the chest), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine spilled), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Re-vaccinated patient), UNDERDOSE (Vaccine spilled) and PAIN (Body aches) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No relevant medical history provided).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced CHEST DISCOMFORT (Tightness in the chest), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine spilled), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Re-vaccinated patient), UNDERDOSE (Vaccine spilled), PAIN (Body aches) and FATIGUE (Severe fatigue). On 03-Mar-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine spilled), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Re-vaccinated patient) and UNDERDOSE (Vaccine spilled) had resolved. At the time of the report, CHEST DISCOMFORT (Tightness in the chest) and PAIN (Body aches) had not resolved and FATIGUE (Severe fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   There was no concomitant list.  Treatment medication not provided.   Reporter did not allow further contact
Woke the following day(Saturday) at 6am with a fever & Chills. 8am took daily blood pressure, instead of the usual 140/74, it was 190/110. Average pulse is 64-72, Pulse was 112! Unable to reach my MD, Not ready to be dumped curb side at a local E.R., I took another Lisinopril 4omg. (Daily dose taken at 11pm).  By 1pm my Blood pressure was 172/ 90, pulse was 100. Took Tylenol for low grade fever at 10pm. Sunday-The next am, B/P was 124/72, pulse was 68, temp was near normal. Normal Vitals on Monday & Tuesday.
Had DTAP and MMR vaccines left thigh on 6/4/2012, yesterday afternoon began developing redness and swelling front of the left thigh per mother, child scratching at the area, redness and swelling measured 5 cm. last eve, now 10 cm. size, using acetaminophen for discomfort, no loratadine past 2 days, hx per mother. The patient is a 4 year, 1 month old female who presents with a complaint of skin problems. The onset of the skin problems has been acute and they have been occurring in a persistent pattern for 1 day. The course has been increasing. The problem is characterized as other (see HPI). Lesions are described as red. The spots were first seen on the lower extremity (Left). There has been associated itching.
After getting vaccinated, pt travelled for a conference that evening around 7pm. Pt felt light-headed and dizzy. Developed headache on left side of head. Feet and hands swollen. Pt stated she felt hot and cold. On 7/30/04, during conference pt's head, face and neck felt itchy. Developed a hive on right cheek, blurred vision. Pt states she felt "out of it". Left conference on 7/31 and stated she passed out 2x at the wheel driving back. Pt called ER evening of 7-31 and doctor on call advised pt to call an ambulance. Pt refused due to limited Finances and lack of insurance. Pt took Advil over weekend of 7-31 and 8/1 for headache. As of 8/2, itchiness and hives had resolved but pt still felt ill with dizziness and blurred vision. Advised pt to seek medical evaluation ASAP for these sx. Pt works in health dept: nursing supervisor walked pt to partnering health center for immediate medical evaluation.
Patient started to get minor rash around chin area after first dose of Moderna vaccine on 04/24/2021. Patient did not report it initially because she thought it was related to her mask wearing. Patient states she did not have any adverse reaction at the time of the second dose. After the second dose was administered, the patient called the pharmacy 2 weeks after the administration date to report a rash. Patient was informed to seek medical attention.
Developed erythematous, pruritus papules over entire body/face after receiving second dose of influenza vaccine likely allergic reaction. Information received from medical records includes fever, vomiting, viral illness. msv
Severe itching all over body, beet red chest and underarms.  I was given Prednosone dosepack for 1 week
My right neck shoulder region started hurting approximately 7 hours after the vaccination and progressively increase in pain. I took Tylenol 1300mg on Tuesday evening. I woke up Wednesday morning with some discomfort and decided to take another dose of Tylenol 1300mg approximately 10:00 am. The pain increased and I took another dose of Tylenol 1300 mg approximately 1500. Tylenol was not relieving my discomfort and approximately at 1800 I took Celebrex 200 mg . I went to bed at 2200. Lying down was difficult. I could not turn my head from side to side without excruciating pain. I finally went to sleep. I woke up Thursday morning pain free.
mild discomfort to my urethra; UTI symptoms; Burning upon urination; pain upon urination; urgency; frequency; This is a spontaneous report from a non-contactable healthcare professional (patient). A 30-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number: EL0140) solution for injection, via an unspecified route of administration in left arm on 28Dec2020 15:45 at a single dose for Covid-19 immunization. Medical history included Hashimoto's Thyroiditis. Patient was not pregnant. The patient's concomitant medications included levothyroxine, unspecified daily multivitamin, and collagen. The patient previously took trimethoprim/sulfamethoxazole (BACTRIM) and had allergies. The patient experienced UTI symptoms, burning upon urination, pain upon urination, urgency, and frequency on 29Dec2020, and mild discomfort to her urethra on an unspecified date. The patient visited her physician. Patient received antibiotic - Keflex. The patient underwent lab tests which included culture: no bacterial growth on an unknown date, Covid-19 rapid swab: negative on an unknown date, and urine analysis: urine had leukocytes and blood present on an unknown date. Outcome of the event mild discomfort to my urethra was unknown while the rest was recovered.  No follow-up attempts are possible. No further information is expected. Information about lot/batch number has been obtained.
red/pinkish injection site after 1st dose; chills; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (red/pinkish injection site after 1st dose) and CHILLS (chills) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 036B21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD, Dizzy and Weakness generalized. Concomitant products included WARFARIN, METOPROLOL, FUROSEMIDE, LORAZEPAM, SIMVASTATIN and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication, ASCORBIC ACID.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (red/pinkish injection site after 1st dose) and CHILLS (chills). On 12-Mar-2021, INJECTION SITE ERYTHEMA (red/pinkish injection site after 1st dose) had resolved and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication included trilogy   This case was linked to US-MODERNATX, INC.-MOD-2021-071343 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-071343:First dose vaccination